Assessing venous thromboembolism risk in pregnant women

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the risk of venous thromboembolism (VTE) in pregnant women using a newly developed risk stratification tool called the Lyon-VTE score. The tool is designed to help clinicians assess individual risk factors for VTE and make informed decisions regarding prophylactic anticoagulation. By tailoring management strategies based on this score, the study seeks to improve outcomes for pregnant women at high risk of VTE. The study will involve adult pregnant women with a personal history of VTE or thrombophilia who consent to participate.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult pregnant women at high risk of VTE (with a personal history of VTE and/or thrombophilia)
* At the time of inclusion, be at most in the 7th month of pregnancy
* giving informed consent to participate to the study

Exclusion Criteria:

* contraindication to heparin therapy,
* women with obstetrical complications only, with no history of VTE (pre-eclampsia, HELLP\[ Hemolysis, Elevated Liver enzymes, Low Platelet count\],intra-uterine growth retardation, miscarriage, etc),
* patients with a history of superficial venous thrombosis, and those with the highest VTE risk for whom clear recommendations with a high level of evidence are available (patients on long-term anticoagulants, or those with antiphospholipid syndrome or antithrombin deficiency).
* Patient participating in an ongoing study that could interfere with the study,
* Patient under legal protection measure.

Where it's running

• Hôpital Cardiologique L. Pradel
  Bron, France Recruiting

Study contacts

• Principal investigator: Yesim DARGAUD, Pr — Hospices Civils de Lyon
• Study coordinator: Yesim DARGAUD, Pr
• Email: ydargaud@univ-lyon1.fr
• Phone: 4 72118810

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide

  This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.

  Recruiting Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida · Paris · NCT07921472

• Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy

  This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.

  Recruiting Kahramanmaras Sutcu Imam University · Kahramanmaraş · NCT07919548

• Effective Communication in VBAC Counseling

  This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.

  Recruiting IRCCS San Raffaele · Milan, MI · NCT07919145

• Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy

  This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.

  Recruiting at 5 sites Austin Health · Hobart and 6 other locations · NCT07916727

• Compare spinal-epidural versus general anesthesia for babies after cesarean delivery

  This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.

  Recruiting Second Affiliated Hospital of Wenzhou Medical University · Wenzhou · NCT07852624

• Pregnant women weight-management support via an app and care model

  Aims to try a smartphone-based weight-management program plus professional support for pregnant women to see if it helps manage gestational weight and promote healthy behaviors.

  Recruiting Mackay Medical College · Taipei · NCT07814885

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.